SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-18-041934
Filing Date
2018-02-13
Accepted
2018-02-13 12:59:04
Documents
1
Group Members
CALEB WINDEREXCEL VENTURES II GP, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d513656dsc13ga.htm SC 13G/A 155056
  Complete submission text file 0001193125-18-041934.txt   156751
Mailing Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199
Business Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199 (617) 450-9800
Excel Venture Fund II, L.P. (Filed by) CIK: 0001538240 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89598 | Film No.: 18601467
SIC: 2834 Pharmaceutical Preparations